The sponsor team walks through the project, the capital stack and the immigration position, then answers whatever is asked. No slides you have not already seen in the briefing document — the value is the questions.
| Date | Time |
|---|---|
| August 5, 2026 | 17:00 Pacific |
| August 12, 2026 | 17:00 Pacific |
| August 19, 2026 | 17:00 Pacific |
| August 26, 2026 | 17:00 Pacific |
Important disclosures. This material is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security. Any offering is made only through the confidential private placement memorandum, operating agreement and subscription documents of EB-5 Healthcare Fund II Mezz, LLC (the "Offering Documents"), which should be read in their entirety.
Interests are offered under Rule 506(c) of Regulation D under the Securities Act of 1933 and are available only to verified accredited investors. Self-certification is not sufficient: prospective investors must complete third-party verification of accredited status before subscribing.
An investment in this offering involves substantial risk, including illiquidity, the risk of construction and operating delay, and the risk of total loss of principal. Under the EB-5 Reform and Integrity Act of 2022 capital must remain at risk; capital that is not at risk does not support an immigration petition. Past performance and prior adjudication times are not indicative of future results.
Nothing herein is legal, tax or immigration advice. Immigration benefits, including I-526E and I-829 adjudication and permanent residence, are determined solely by U.S. Citizenship and Immigration Services and by the U.S. Department of State. No result is guaranteed. Prospective investors must retain their own immigration counsel and tax advisers.